In Ovations Holdings, Inc. announced the implementation of the technology using sputum cytology for the early detection of lung cancer, a recognized laboratory procedure similar to the 'Pap' test.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -.--% | -.--% |
2017 | In Ovations Holdings, Inc. Appoints Kenneth Hughes as Chief Science Officer | CI |
2017 | In Ovations Holdings, Inc. Announces Resignation of Rosendo Alvarez III as Officer and Director | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 5.56K | |
+15.73% | 70.23B | |
+5.46% | 17.08B | |
+12.50% | 13.77B | |
+19.72% | 13.57B | |
+15.64% | 10.15B | |
-16.85% | 7.04B | |
-1.01% | 6.18B | |
+3.17% | 5.27B | |
+0.45% | 5.06B |
- Stock Market
- Equities
- INOH Stock
- News In Ovations Holdings, Inc.
- In Ovations Holdings, Inc. Announces the Availability of the Early Detection of Lung Cancer Kit